The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated ...
Cemiplimab significantly reduced the risk of recurrence or death in patients with high-risk cutaneous squamous cell carcinoma ...
Women who are using heroin and were recently incarcerated had increased stimulant use, which is associated with adverse ...
The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.
Mutations in one of the first human-isolated strains of H5N1 bird flu in the US were identified by the Texas Biomedical ...
The Affordable Care Act (ACA) led to reductions in out-of-pocket costs and improvements in health among adults entering ...
The Bruton tyrosine kinase inhibitor was approved in combination with bendamustine and rituximab in previously untreated ...
Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
Semaglutide (Ozempic) is 1 of 15 medications that will be included in yearly price negotiations between Medicare and ...
The combination treatment specifically targets KRAS-mutated metastatic colorectal cancer (CRC) to improve progression-free ...
High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced ...